Amphetamine Levels in Brain Microdialysate, Caudate/putamen, Substantia Nigra and Plasma After Dosage That Produces Either Behavioral or Neurotoxic Effects
Overview
Affiliations
Extracellular levels of d-amphetamine (AMPH) in caudate/putamen were determined using microdialysis and HPLC quantitation after s.c. doses that produced increased motor activity (1 mg/kg), stereotypic behavior (2.5 mg/kg) or dopamine depletion in the caudate/putamen (4 x 5 mg/kg). In 6-mo-old rats exposed to neurotoxic doses of AMPH sulfate (4 x 5 mg/kg in a 23 degrees C environment), extracellular caudate/putamen AMPH rose to levels of 7.9 +/- 0.9 microM after the first dose and peaked at 15.1 +/- 2.5 microM after the third dose with no further increases after the fourth dose. After one or three doses of 5 mg/kg, peak plasma and tissue levels of AMPH were 1.7 +/- 0.2 and 2.9 +/- 0.3 microM in plasma, 36 +/- 6 and 73 +/- 10 in substantia nigra and 25 +/- 4 and 50 +/- 8 in caudate/putamen, respectively. Caudate/putamen extracellular AMPH levels were about three times higher (in either 6- or 12-mo-old rats) after 4 x 15 mg/kg in a 10 degrees C environment and tissue levels in caudate/putamen and substantia nigra were three to five times higher after three doses of AMPH. However, these higher levels did not produce dopamine depletion in the caudate/putamen, while the lower doses (4 x 5 mg/kg) given at 23 degrees C did. Estimated caudate/putamen extracellular AMPH levels of 2.5 to 5 microM after single doses (1 and 2.5 mg/kg) that caused hyperactivity and stereotypic behavior are compatible with the 2 to 10 microM AMPH concentrations reported to be necessary to produce pronounced dopamine release in vitro.(ABSTRACT TRUNCATED AT 250 WORDS)
An unsuspected role for organic cation transporter 3 in the actions of amphetamine.
Mayer F, Schmid D, Owens W, Gould G, Apuschkin M, Kudlacek O Neuropsychopharmacology. 2018; 43(12):2408-2417.
PMID: 29773909 PMC: 6180071. DOI: 10.1038/s41386-018-0053-5.
Bowyer J, Hanig J Temperature (Austin). 2016; 1(3):172-82.
PMID: 27626044 PMC: 5008711. DOI: 10.4161/23328940.2014.982049.
Freyberg Z, Sonders M, Aguilar J, Hiranita T, Karam C, Flores J Nat Commun. 2016; 7:10652.
PMID: 26879809 PMC: 4757768. DOI: 10.1038/ncomms10652.
Rickhag M, Owens W, Winkler M, Strandfelt K, Rathje M, Sorensen G J Biol Chem. 2013; 288(38):27534-27544.
PMID: 23884410 PMC: 3779749. DOI: 10.1074/jbc.M112.441295.
German C, Hanson G, Fleckenstein A J Neurochem. 2012; 123(2):288-97.
PMID: 22804716 PMC: 3962019. DOI: 10.1111/j.1471-4159.2012.07875.x.